Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Sonobe

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Chemical & Pharmaceutical Bulletin|August 1, 1986
Dissolution and bioavailability of phenytoin in phenytoin-polyvinylpyrrolidone-sodium deoxycholate coprecipitateS Yakou, S Yamazaki, T Sonobe, et al.
International Journal of Pharmaceutics|June 19, 2001
Stabilization of minodronic acid in aqueous solution for parenteral formulationK Nakamura, T Tanaka, K Saito, et al.
Chemical & Pharmaceutical Bulletin|March 1, 1984
Sustained-release formulation of buformin hydrochlorideY Sawayanagi, T Sonobe, H Kawata, et al.
Journal of Dental Research|April 1, 1977
Synchronized crystal dissolution behavior for tooth enamel and synthetic (NBS) hydroxyapatiteM B Fawzi, T Sonobe, W I Higuchi, et al.
Japanese Journal of Cancer Research : Gann|September 2, 1999
Membrane transport and antitumor activity of pirarubicin, and comparison with those of doxorubicinT Sugiyama, Y Sadzuka, K Nagasawa, et al.
Pharmaceutical Research|May 1, 1996
Enhancement of nasal salmon calcitonin absorption by lauroylcarnitine chloride in ratsS Kagatani, T Shinoda, M Fukui, et al.
Chemical & Pharmaceutical Bulletin|September 1, 1986
Studies on antitumor cyclic hexapeptides RA obtained from rubiae radix, rubiaceae. VI. Minor antitumor constituentsH Itokawa, K Takeya, N Mori, et al.
Artificial Organs|July 1, 1997
Hemolysis test of disposable type vibrating flow pumpS Kobayashi, S Nitta, T Yambe, et al.
Chemical & Pharmaceutical Bulletin|October 1, 1986
Particle size distribution affects the human bioavailability of phenytoinS Yakou, S Yamazaki, T Sonobe, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi|August 23, 2008
[The utility of coronary magnetic resonance angiography in children under six years of age with Kawasaki disease]A Takemura, A Suzuki, T Kitazume, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Chemical & Pharmaceutical Bulletin|August 1, 1986
Dissolution and bioavailability of phenytoin in phenytoin-polyvinylpyrrolidone-sodium deoxycholate coprecipitateS Yakou, S Yamazaki, T Sonobe, et al.
International Journal of Pharmaceutics|June 19, 2001
Stabilization of minodronic acid in aqueous solution for parenteral formulationK Nakamura, T Tanaka, K Saito, et al.
Chemical & Pharmaceutical Bulletin|March 1, 1984
Sustained-release formulation of buformin hydrochlorideY Sawayanagi, T Sonobe, H Kawata, et al.
Journal of Dental Research|April 1, 1977
Synchronized crystal dissolution behavior for tooth enamel and synthetic (NBS) hydroxyapatiteM B Fawzi, T Sonobe, W I Higuchi, et al.
Japanese Journal of Cancer Research : Gann|September 2, 1999
Membrane transport and antitumor activity of pirarubicin, and comparison with those of doxorubicinT Sugiyama, Y Sadzuka, K Nagasawa, et al.
Pharmaceutical Research|May 1, 1996
Enhancement of nasal salmon calcitonin absorption by lauroylcarnitine chloride in ratsS Kagatani, T Shinoda, M Fukui, et al.
Chemical & Pharmaceutical Bulletin|September 1, 1986
Studies on antitumor cyclic hexapeptides RA obtained from rubiae radix, rubiaceae. VI. Minor antitumor constituentsH Itokawa, K Takeya, N Mori, et al.
Artificial Organs|July 1, 1997
Hemolysis test of disposable type vibrating flow pumpS Kobayashi, S Nitta, T Yambe, et al.
Chemical & Pharmaceutical Bulletin|October 1, 1986
Particle size distribution affects the human bioavailability of phenytoinS Yakou, S Yamazaki, T Sonobe, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi|August 23, 2008
[The utility of coronary magnetic resonance angiography in children under six years of age with Kawasaki disease]A Takemura, A Suzuki, T Kitazume, et al.
Pageof 10